Literature DB >> 4067589

Hepatitis B virus in Gizan, Saudi Arabia.

S C Arya, S J Ashraf, C M Parande, M el-Sayed, R Sahay, A R Ageel, M S Tobeiqi.   

Abstract

The enzyme-linked immunosorbent assay (ELISA) was used to study the prevalence rates for hepatitis B virus surface antigen (HBsAg), antibody to surface antigen (anti-HBs), and antibody to core antigen (anti-HBc) in 724 voluntary donors, students, pregnant women and those seeking treatment for minor ailments in the Gizan area of Saudi Arabia. Tests for hepatitis B e antigen (HBeAg) and e antibody (anti-HBe) were made in HBsAg positive sera. There was serological evidence of an existing or earlier infection in 337 Saudis (46.5%), of whom 12.7% were HBsAg carriers, 25.4% were positive for anti-HBs, and 8.4% were positive only for anti-HBc. The percentage of HBsAg carriers was 19.9% and 9.3% in males and females, respectively (p less than 0.001). The evidence of existing or earlier infection in males (58.7%) was significantly higher than in females (38.7%) (p less than 0.001), with no intersex difference in anti-HBs or anti-HBc. No difference was observed in the positivity of either of the markers, alone or together, between the cord blood and the female population in the child-bearing age of 20-39 years. Corresponding to the values in other age groups, there was an overall fall in the number of HBsAg carriers during adolescence as well as in 20-39-year-old females. Among the HBsAg carriers, there was no significant difference between the two sexes for HBeAg and anti-HBe positivity. The HBsAg carrier rate of 19.9% in males is consistent with the high male dominant prevalence of hepatocellular carcinoma in the Gizan area.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067589     DOI: 10.1002/jmv.1890170308

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report.

Authors:  M D Aljurf; S Z Zaidi; H El Solh; F Hussain; A Ghavamzadeh; H K Mahmoud; T Shamsi; T Ben Othman; M M Sarhan; D Dennison; A Ibrahim; S Benchekroun; N Chaudhri; B Labar; M Horowitz; D Niederwieser; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2008-12-01       Impact factor: 5.483

2.  Anti-delta antibody in primary hepatocellular carcinoma patients in the Gizan area of Saudi Arabia.

Authors:  S J Ashraf; S C Arya; C M Parande; R Sahay; A R Ageel
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

3.  False-positive ELISA reactivity to hepatitis B virus surface antigen (HBsAg)

Authors:  S C Arya; C M Parande; S J Ashraf
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

4.  Type 2 hepatitis B virus (HBV-2) in carriers and patients with malignancy in Saudi Arabia.

Authors:  S C Arya; V P Pathak; S J Ashraf
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

5.  Hepatitis B virus among Saudi children in Gizan, Saudi Arabia.

Authors:  C M Parande; S C Arya; S J Ashraf
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

6.  Hepatitis B virus sero-prevalence among pregnant females in Saudi Arabia.

Authors:  Mohammed A Alrowaily; Mostafa A Abolfotouh; Mazen S Ferwanah
Journal:  Saudi J Gastroenterol       Date:  2008-04       Impact factor: 2.485

7.  Childhood renal disorders in Saudi Arabia.

Authors:  M B Abdurrahman; A T Elidrissy
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

8.  PATTERN OF HBsAg POSITIVITY IN SELECTED GROUPS AT KING KHALID GENERAL HOSPITAL - HAIL REGION, KINGDOM OF SAUDI ARABIA.

Authors:  H M Mahaba; A el K El-Tayeb; D K El-Sekibi; A F El Gofaei; H S El-Baz; N A Ismail
Journal:  J Family Community Med       Date:  1997-01

Review 9.  Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Authors:  Ayman A Abdo; Faisal M Sanai; Faleh Z Al-Faleh
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

10.  Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population.

Authors:  Khalid A Alswat; Faisal M Sanai; Mansour Altuwaijri; Ali Albenmousa; Majid Almadi; Waleed K Al-Hamoudi; Ayman A Abdo
Journal:  Hepat Mon       Date:  2013-05-08       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.